Zerion is a pharmaceutical company transforming the pharmaceutical landscape for formulation of poorly soluble drugs that are currently not reaching their therapeutic potential. Through the use of our proprietary formulation platform, we aim to develop new treatment options for patients across all small molecule therapy areas. We are focused on improving existing drug products by building an internal pipeline, while partnering with originators to enable their early stage drug molecules, striving to improve the lives of patients around the world.
| Website | https://www.zerion.eu/ |
| Employees | 21 (12 on RocketReach) |
| Founded | 2019 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Drug Formulation, Pharmaceutical Development, Bioavailability Enhancement, Innovative Formulations, Drug Product Development, Therapeutic Potential, Drug Delivery, Advanced Drug Delivery, Pharmaceutical Platform, Oral Drug Delivery, New Drug Development, Dosage Forms, Pharmaceutical Research, Drug Discovery, Pharmaceutical Manufacturing |
| Competitors | Thermo Fisher Scientific, Boehringer Ingelheim, Lonza, Catalent Pharma Solutions, Evonik, Sartorius, Aptar Pharma, Patheon, Recipharm, SMC Deutschland +42 more (view full list) |
Looking for a particular Zerion Pharma employee's phone or email?
Jakob Hansen is the CFO of Zerion Pharma.
12 people are employed at Zerion Pharma.